Login

Camino a la excelencia translates to "Pathway to excellence." 00:10:00

Share On Facebook Share On Twitter

Tomas Cordoba - CEO - MetroGAS

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Exploring Yemen's Untapped Mineral Potential: Kex's Advances in Gold and Sulfide Deposits
00:10:00
From Janitor's Son to Leader: Chad's Journey at JP Morgan Chase
00:10:00
Their goal is to accelerate the emergence of the open metaverse by investing in the founders, companies|Andrew Steinwold,Managing Partner,Sfermion
00:10:00
A Masterclass with Latham & Watkins and the US Chamber of Commerce | Sarah E. Fortt - Partner of Latham & Watkins
00:10:00
Navigating Direct Foreign Investment in Africa's Growing Economy
00:10:00
The EDV is proving safe and effective across a number of late-stage, intractable cancers like pancreatic cancer and mesothelioma| Dr Jennifer MacDiarmid , CEO OF ENGENEIC
00:10:00
"A company that provides value to its users by offering Props, ensuring users see tangible benefits in receiving them."
00:10:00
Transforming Culture: Geoff Yang on AI, Hip Hop, and Investment Insights | Geoff Yang, Co-Founder, Redpoint Ventures.
00:10:00
Demystifying Securitized Fixed Income: Opportunities and Strategies for Investors | John Kerschner, CFA - Head of US Securitised Products | Portfolio Manager of Janus Henderson Investors
00:10:00
De Belegger on Tour - Pitch with Francis Van Eeckhout, CEO Deceuninck | Francis Van Eeckhout - CEO of Deceuninck
00:10:00
Cerro De Pasco Resources CEO Guy Goulet Presents at Metals Investor Forum 2023 | Guy Goulet, CHIEF EXECUTIVE OFFICER of Cerro de Pasco Resources Inc.
00:10:00
Lean Strategy and Customer Satisfaction: Insights from Aramis Group | Nicolas Chartier, CO-Founder, Aramis Group.

© 2026 Nehu